|
Platelets
Citations 211-220 of 381 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease
- Thomas Heitzer, Isabel Ollmann, Katharina Köke, Thomas Meinertz, and Thomas Munzel
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000081774.31064.62
[Abstract]
- Articles
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
- N. Zimmermann, A. Wenk, U. Kim, P. Kienzle, A. -A. Weber, E. Gams, K. Schrör, and T. Hohlfeld
Circulation published July 21, 2003, doi:10.1161/01.CIR.0000081770.51929.5A
[Abstract]
- Articles
Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in Humans
- Hidenori Koyama, Takaaki Maeno, Shinya Fukumoto, Takuhito Shoji, Takahisa Yamane, Hisayo Yokoyama, Masanori Emoto, Tetsuo Shoji, Hideki Tahara, Masaaki Inaba, Masayuki Hino, Atsushi Shioi, Takami Miki, and Yoshiki Nishizawa
Circulation published July 14, 2003, doi:10.1161/01.CIR.0000081765.88440.51
[Abstract]
- Clinical Investigations and Reports
Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction
- William H. Sauer, Jesse A. Berlin, and Stephen E. Kimmel
Circulation 2003;108:32-36; published online before print as doi:10.1161/01.CIR.0000079172.43229.CD
[Abstract]
[Full text]
- Clinical Investigations and Reports
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
- Dwayne S.G. Conway, Lesly A. Pearce, Bernard S.P. Chin, Robert G. Hart, and Gregory Y.H. Lip
Circulation 2003;107:3141-3145; published online before print as doi:10.1161/01.CIR.0000077912.12202.FC
[Abstract]
[Full text]
- Clinical Investigations and Reports
Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus: Role of Interleukin-6 and Disease Duration
- Giovanni Davì, Francesco Chiarelli, Francesca Santilli, Mariapina Pomilio, Sergio Vigneri, Angela Falco, Stefania Basili, Giovanni Ciabattoni, and Carlo Patrono
Circulation 2003;107:3199-3203; published online before print as doi:10.1161/01.CIR.0000074205.17807.D0
[Abstract]
[Full text]
- Correspondence
Atorvastatin–Clopidogrel Interaction • Response
- Paul T. Martin, Russell Denman, Wei C. Lau, Lucy A. Waskell, Charlene J. Neer, Kevin Horowitz, Amy S. Hopp, Alan R. Tait, Eric R. Bates, Paul B. Watkins, David G.M. Carville, and Kirk E. Guyer
Circulation 2003;107:e223, doi:10.1161/01.CIR.0000077528.26542.DC
[Full text]
- Articles
Effect of Antidepressants and Their Relative Affinity for the Serotonin Transporter on the Risk of Myocardial Infarction
- William H. Sauer, Jesse A. Berlin, and Stephen E. Kimmel
Circulation published June 23, 2003, doi:10.1161/01.CIR.0000079172.43229.CD
[Abstract]
- Clinical Investigations and Reports
Clopidogrel for Coronary Stenting: Response Variability, Drug Resistance, and the Effect of Pretreatment Platelet Reactivity
- Paul A. Gurbel, Kevin P. Bliden, Bonnie L. Hiatt, and Christopher M. O’Connor
Circulation 2003;107:2908-2913; published online before print as doi:10.1161/01.CIR.0000072771.11429.83
[Abstract]
[Full text]
- Articles
Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes Mellitus. Role of Interleukin-6 and Disease Duration
- Giovanni Davì, Francesco Chiarelli, Francesca Santilli, Mariapina Pomilio, Sergio Vigneri, Angela Falco, Stefania Basili, Giovanni Ciabattoni, and Carlo Patrono
Circulation published June 16, 2003, doi:10.1161/01.CIR.0000074205.17807.D0
[Abstract]
|
|
